N-glycoprotein profiling of lung adenocarcinoma pleural effusions by shotgun proteomics.

作者: Alex Soltermann , Reto Ossola , Sandra Kilgus-Hawelski , Arnold von Eckardstein , Tobias Suter

DOI: 10.1002/CNCR.23349

关键词:

摘要: BACKGROUND Malignant pleural effusion of advanced lung adenocarcinoma may be a valid source for detection biomarkers, such as N-glycosylated proteins (N-GP), because tumor cells grow during weeks in this liquid. The authors aimed creation N-GP profiles from routine cytology specimens to detect relevant biomarkers. METHODS Hundred microliters malignant effusions 5 patients with and nonmalignant controls were used triplicate capture by solid-phase extraction. After trypsin digest PNGase F release, liquid chromatography separation connected online tandem mass spectrometer was performed chromatography/tandem spectrometry (LC/MS/MS). RESULTS In the total 10 samples, 170 278 nonredundant detected probabilities ≥.9 ≥.5, respectively. specificity N-glycomotif 88% at P ≥ .9. Penetration into moderate low protein concentration range (μg-ng/mL) occurred, several associated progression or metastasis identified, including CA-125, CD44, CD166, lysosome-associated membrane glycoprotein 2 (LAMP-2), multimerin 2, periostin. MS identifications correlated corresponding immunoreactivity either fluid tissue. CONCLUSIONS In conclusion, reduction sample complexity capturing allows μg ng/mL range. Pleural is useful biomarker research cancer. Cancer (Cancer Cytopathol) 2008. © 2008 American Society.

参考文章(30)
Tao Liu, Wei-Jun Qian, Marina A. Gritsenko, David G. Camp, Matthew E. Monroe, Ronald J. Moore, Richard D. Smith, Human Plasma N-Glycoproteome Analysis by Immunoaffinity Subtraction, Hydrazide Chemistry, and Mass Spectrometry Journal of Proteome Research. ,vol. 4, pp. 2070- 2080 ,(2005) , 10.1021/PR0502065
N. Berkman, M. R. Kramer, Diagnostic tests in pleural effusion : an update Postgraduate Medical Journal. ,vol. 69, pp. 12- 18 ,(1993) , 10.1136/PGMJ.69.807.12
Beat M. Künzli, Pascal O. Berberat, Zhaowhen W. Zhu, Marcus Martignoni, Jörg Kleeff, Adrien A. Tempia-Caliera, Minoru Fukuda, Arthur Zimmermann, Helmut Friess, Markus W. Büchler, Influences of the lysosomal associated membrane proteins (Lamp-1, Lamp-2) and Mac-2 binding protein (Mac-2-BP) on the prognosis of pancreatic carcinoma Cancer. ,vol. 94, pp. 228- 239 ,(2002) , 10.1002/CNCR.10162
Hidefumi Sasaki, Chih-Yi Yu, Meiru Dai, Carmen Tam, Massimo Loda, Daniel Auclair, Lan Bo Chen, Anthony Elias, Elevated Serum Periostin Levels in Patients with Bone Metastases from Breast but not Lung Cancer Breast Cancer Research and Treatment. ,vol. 77, pp. 245- 252 ,(2003) , 10.1023/A:1021899904332
Andrea D. Weston, Leroy Hood, Systems biology, proteomics, and the future of health care: toward predictive, preventative, and personalized medicine. Journal of Proteome Research. ,vol. 3, pp. 179- 196 ,(2004) , 10.1021/PR0499693
Ben Davidson, Malignant effusions: from diagnosis to biology. Diagnostic Cytopathology. ,vol. 31, pp. 246- 254 ,(2004) , 10.1002/DC.20133
Yasusei Kudo, Ikuko Ogawa, Shojiro Kitajima, Masae Kitagawa, Hidehiko Kawai, Patrick M. Gaffney, Mutsumi Miyauchi, Takashi Takata, Periostin Promotes Invasion and Anchorage-Independent Growth in the Metastatic Process of Head and Neck Cancer Cancer Research. ,vol. 66, pp. 6928- 6935 ,(2006) , 10.1158/0008-5472.CAN-05-4540
Hidefumi Sasaki, Daniel Auclair, Ichiro Fukai, Masanobu Kiriyama, Yosuke Yamakawa, Yoshitaka Fujii, Lan Bo Chen, Serum level of the periostin, a homologue of an insect cell adhesion molecule, as a prognostic marker in nonsmall cell lung carcinomas. Cancer. ,vol. 92, pp. 843- 848 ,(2001) , 10.1002/1097-0142(20010815)92:4<843::AID-CNCR1391>3.0.CO;2-P
Shideng Bao, Gaoliang Ouyang, Xuefang Bai, Zhi Huang, Chaoyu Ma, Ming Liu, Rong Shao, Ryan M Anderson, Jeremy N Rich, Xiao-Fan Wang, Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway Cancer Cell. ,vol. 5, pp. 329- 339 ,(2004) , 10.1016/S1535-6108(04)00081-9